Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-20 4:31 pm Sale | 2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 3,009,021 2.760% | -4,878,815 (-61.85%) | Filing History |
| 2024-12-04 4:31 pm Purchase | 2024-11-27 | 13G | InspireMD, Inc. NSPR | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 1,411,636 5.220% | 1,411,636 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Surrozen, Inc. SRZN | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 176,970 5.280% | 176,970 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 7,887,836 7.760% | 5,766,083 (+271.76%) | Filing History |
| 2024-02-02 8:32 pm Purchase | 2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2,121,753 6.100% | 2,121,753 (New Position) | Filing History |